Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single-blind Crossover Study of the Pharmacokinetic and Postprandial Glucose Dynamics of BIOD-531 Compared to Humulin R U-500 and Humalog Mix75/25 in Subjects With Type 2 DM Who Are Treated With ≥ 150 Units of Insulin Per Day

Next Previous
Trial Profile

A Single-blind Crossover Study of the Pharmacokinetic and Postprandial Glucose Dynamics of BIOD-531 Compared to Humulin R U-500 and Humalog Mix75/25 in Subjects With Type 2 DM Who Are Treated With ≥ 150 Units of Insulin Per Day

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 Feb 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin (Primary) ; Insulin neutral protamine lispro/insulin lispro
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Biodel

    • Most Recent Events

    • 14 Sep 2015 According to a Biodel media release, results from this study will be presented at the 51st Annual Meeting of the European Association for the Study of Diabetes (EASD).
    • 09 Jun 2015 Results (pre- and post-prandial blood glucose concentrations) presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
    • 07 Jan 2015 Status changed from active, no longer recruiting to completed, according to a Biodel media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top